DE60133377D1 - Dezellularisierte gefässprothesen - Google Patents
Dezellularisierte gefässprothesenInfo
- Publication number
- DE60133377D1 DE60133377D1 DE60133377T DE60133377T DE60133377D1 DE 60133377 D1 DE60133377 D1 DE 60133377D1 DE 60133377 T DE60133377 T DE 60133377T DE 60133377 T DE60133377 T DE 60133377T DE 60133377 D1 DE60133377 D1 DE 60133377D1
- Authority
- DE
- Germany
- Prior art keywords
- present
- prostheses
- immunogenicity
- vascular
- valves
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3625—Vascular tissue, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20022000P | 2000-04-28 | 2000-04-28 | |
US200220P | 2000-04-28 | ||
PCT/US2001/013617 WO2001082992A1 (en) | 2000-04-28 | 2001-04-27 | Decellularized vascular prostheses |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60133377D1 true DE60133377D1 (de) | 2008-05-08 |
DE60133377T2 DE60133377T2 (de) | 2009-01-02 |
Family
ID=22740806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60133377T Expired - Fee Related DE60133377T2 (de) | 2000-04-28 | 2001-04-27 | Dezellularisierte gefässprothesen |
Country Status (8)
Country | Link |
---|---|
US (2) | US6689161B2 (de) |
EP (1) | EP1278559B1 (de) |
JP (1) | JP2003531685A (de) |
AT (1) | ATE390152T1 (de) |
AU (2) | AU2001255741B2 (de) |
CA (1) | CA2407328A1 (de) |
DE (1) | DE60133377T2 (de) |
WO (1) | WO2001082992A1 (de) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001122791A (ja) * | 1999-10-20 | 2001-05-08 | Boehringer Ingelheim Internatl Gmbh | 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤 |
WO2002014480A2 (en) * | 2000-08-16 | 2002-02-21 | Duke University | Decellularized tissue engineered constructs and tissues |
NL1019316C2 (nl) * | 2001-11-06 | 2003-05-07 | Tno | Een vasculaire prothese. |
NZ536331A (en) * | 2002-05-09 | 2007-08-31 | Hemoteq Ag | Compounds and method for coating surfaces of medical devices such as stents in a haemocompatible manner |
JP4092397B2 (ja) * | 2002-09-10 | 2008-05-28 | 国立循環器病センター総長 | 超高静水圧印加による移植用生体組織の処理方法 |
WO2004038004A2 (en) * | 2002-10-23 | 2004-05-06 | The Research Foundation Of State University Of Newyork | Fibrin-based tissue-engineered vasculature |
US20040151769A1 (en) * | 2002-12-31 | 2004-08-05 | Boehringer Ingelheim International Gmbh | Film coated tablet containing an extract of red vine leaves |
US20040151794A1 (en) * | 2002-12-31 | 2004-08-05 | Boehringer Ingelheim International Gmbh | Method of improvement of blood circulation |
AU2004226551A1 (en) * | 2003-03-31 | 2004-10-14 | Teijin Limited | Molded elastin article and process for producing the same |
EP2335648A1 (de) * | 2003-04-28 | 2011-06-22 | Kips Bay Medical, Inc. | Nachgiebiges Venentransplantat |
US7998188B2 (en) | 2003-04-28 | 2011-08-16 | Kips Bay Medical, Inc. | Compliant blood vessel graft |
US20050131520A1 (en) * | 2003-04-28 | 2005-06-16 | Zilla Peter P. | Compliant blood vessel graft |
US20050288756A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050125049A1 (en) * | 2003-10-21 | 2005-06-09 | The Regents Of The University Of Michigan | Tissue engineered vascular construct and method for producing same |
EP1550451A1 (de) * | 2003-12-29 | 2005-07-06 | Boehringer Ingelheim International GmbH | Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben und einem Diuretika |
EP1550450A1 (de) * | 2003-12-29 | 2005-07-06 | Boehringer Ingelheim International GmbH | Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben und einem Blutumlauf verbesserndes Mittel |
RU2367464C2 (ru) * | 2004-02-19 | 2009-09-20 | Берингер Ингельхайм Интернациональ Гмбх | Состав для лечения хронических венозных недостаточностей, содержащий водный экстракт листьев красного винограда и противовоспалительное средство |
US20060282173A1 (en) * | 2004-03-09 | 2006-12-14 | Mcfetridge Peter S | Substantially decellularized grafts from umbilical cord vessels and process for preparing and using same |
US7775965B2 (en) * | 2004-03-09 | 2010-08-17 | The Board Of Regents Of The University Of Oklahoma | Decellularized grafts from umbilical cord vessels and process for preparing and using same |
NZ549953A (en) * | 2004-03-17 | 2010-11-26 | Revivicor Inc | Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
WO2005096988A1 (en) * | 2004-04-01 | 2005-10-20 | Cook Incorporated | A device for retracting the walls of a body vessel with remodelable material |
EP1737390A1 (de) * | 2004-04-08 | 2007-01-03 | Cook Incorporated | Implantierbares medizinprodukt mit optimierter form |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
US7563276B2 (en) * | 2004-10-29 | 2009-07-21 | Cook Incorporated | Intraluminal medical device with cannula for controlled retrograde flow |
EP1898937B1 (de) * | 2005-07-01 | 2012-11-28 | Corline Systems AB | Heparinbeschichtung von biologischem gewebe |
CN1903143A (zh) * | 2005-07-29 | 2007-01-31 | 广东冠昊生物科技有限公司 | 生物型人工血管及其制备方法 |
CN100482178C (zh) * | 2005-08-04 | 2009-04-29 | 广东冠昊生物科技有限公司 | 带生物膜的血管瘤夹 |
PL1928519T3 (pl) | 2005-08-26 | 2012-08-31 | Univ Minnesota | Decelularyzacja i recelularyzacja narządów i tkanek |
US20100093066A1 (en) * | 2005-08-26 | 2010-04-15 | Regents Of The University Of Minnesota | Decellularization and recellularization apparatuses and systems containing the same |
US7658706B2 (en) * | 2005-12-05 | 2010-02-09 | Rti Biologics, Inc. | Vascular graft sterilization and decellularization |
CN1986006A (zh) * | 2005-12-20 | 2007-06-27 | 广州知光生物科技有限公司 | 生物型神经导管 |
WO2007124127A2 (en) * | 2006-04-21 | 2007-11-01 | Wake Forest University Health Sciences | Structurally modified acellular tissue engineering scaffolds and methods of production |
US8021677B2 (en) | 2006-05-12 | 2011-09-20 | Gore Enterprise Holdings, Inc. | Immobilized biologically active entities having a high degree of biological activity |
US8986713B2 (en) * | 2006-05-12 | 2015-03-24 | W. L. Gore & Associates, Inc. | Medical device capable of being compacted and expanded having anti-thrombin III binding activity |
US20080279909A1 (en) * | 2006-05-12 | 2008-11-13 | Cleek Robert L | Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization |
US8496953B2 (en) * | 2006-05-12 | 2013-07-30 | W. L. Gore & Associates, Inc. | Immobilized biologically active entities having a high degree of biological activity following sterilization |
US9114194B2 (en) * | 2006-05-12 | 2015-08-25 | W. L. Gore & Associates, Inc. | Immobilized biologically active entities having high biological activity following mechanical manipulation |
CN101332314B (zh) * | 2008-07-22 | 2012-11-14 | 广东冠昊生物科技股份有限公司 | 生物型关节软骨修补件 |
US20100023129A1 (en) * | 2008-07-22 | 2010-01-28 | Guo-Feng Xu | Jawbone prosthesis and method of manufacture |
US8162815B2 (en) * | 2007-01-16 | 2012-04-24 | Mark Genovesi | Method and device for preserving the vitality and function of a harvested blood vessel |
US8764828B2 (en) * | 2007-02-02 | 2014-07-01 | The Regents Of The University Of Michigan | System and method for forming bone, ligament, and bone-ligament constructs |
US20100179639A1 (en) * | 2007-04-16 | 2010-07-15 | Stephen Bloor | Vascular implant |
EP2178576A2 (de) * | 2007-04-16 | 2010-04-28 | Tissue Science Laboratories PLC | Knochenimplantat |
WO2008125850A2 (en) * | 2007-04-16 | 2008-10-23 | Tissue Science Laboratories Plc | Methods and compositions for tissue regeneration |
US20080306610A1 (en) * | 2007-06-07 | 2008-12-11 | Zimmer Orthobiologics, Inc. | Tissue processing for nonimmunogenic implants |
EP2022511A1 (de) | 2007-08-06 | 2009-02-11 | Corlife GbR | Bioaktive Beschichtung für eine implantierbare Vorrichtung oder eine Bioprothese |
WO2009044407A1 (en) * | 2007-10-03 | 2009-04-09 | International Centre For Cardio Thoracic And Vascular Diseases (A Unit Of Frontier Lifeline Pvt. Ltd) | Small diameter vascular graft from processed cadaver saphenous vein |
US7846199B2 (en) * | 2007-11-19 | 2010-12-07 | Cook Incorporated | Remodelable prosthetic valve |
US20090163990A1 (en) * | 2007-12-19 | 2009-06-25 | Chunlin Yang | Decellularized omentum matrix and uses thereof |
JP5855460B2 (ja) * | 2008-11-24 | 2016-02-09 | ヴァスキュラー グラフト ソリューションズ リミテッド | 外部ステント |
WO2010111263A1 (en) | 2009-03-23 | 2010-09-30 | Wake Forest University Health Sciences | Tissue engineering scaffolds and methods of use |
US8591932B2 (en) * | 2009-09-17 | 2013-11-26 | W. L. Gore & Associates, Inc. | Heparin entities and methods of use |
US8435305B2 (en) | 2010-08-31 | 2013-05-07 | Zimmer, Inc. | Osteochondral graft delivery device and uses thereof |
US10233420B2 (en) | 2010-09-01 | 2019-03-19 | Regents Of The University Of Minnesota | Methods of recellularizing a tissue or organ for improved transplantability |
CN102475919B (zh) * | 2010-11-29 | 2015-04-29 | 吴忠仕 | 一种去细胞生物组织材料肝素涂层的制备方法 |
CN103596603B (zh) | 2011-03-11 | 2016-01-20 | W.L.戈尔及同仁股份有限公司 | 固定的生物实体的改进 |
US9623051B2 (en) * | 2011-04-15 | 2017-04-18 | The Regents Of The University Of California | Decellularized extracellular matrix |
WO2012143925A1 (en) | 2011-04-18 | 2012-10-26 | Vascular Graft Solutions Ltd | Devices and methods for deploying implantable sleeves over blood vessels |
US9290738B2 (en) | 2012-06-13 | 2016-03-22 | Miromatrix Medical Inc. | Methods of decellularizing bone |
US9125959B1 (en) * | 2012-10-17 | 2015-09-08 | University Of South Florida | Compositions and methods for reducing or preventing medical device-related infections |
US10058630B2 (en) | 2012-10-22 | 2018-08-28 | Concievalve, Llc | Methods for inhibiting stenosis, obstruction, or calcification of a stented heart valve or bioprosthesis |
ES2831756T3 (es) | 2013-03-15 | 2021-06-09 | Miromatrix Medical Inc | Uso de hígado descelularizado por perfusión para la recelularización de células de islotes |
EP2787069B1 (de) * | 2013-04-04 | 2015-08-05 | Universität Leipzig | Verfahren und Vorrichtung zur Dezellularisierung von Organen und Geweben |
US9981066B2 (en) * | 2013-05-20 | 2018-05-29 | Yale University | Anti-thrombogenic grafts |
AU2014296259B2 (en) | 2013-07-30 | 2017-04-27 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
EP3060174B1 (de) * | 2013-10-22 | 2020-05-27 | Concievalve LLC | Verfahren zur hemmung von stenose, obstruktionen oder verkalkung einer gestenteten herzklappe oder bioprothese |
JP6515429B2 (ja) * | 2013-12-16 | 2019-05-22 | 国立研究開発法人国立循環器病研究センター | 人工血管、および、人工血管の製造方法 |
US11033661B2 (en) * | 2015-03-12 | 2021-06-15 | Adeka Corporation | Anti-adhesion material and substitute biomembrane using decellularized tissue |
US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
CN108495659A (zh) | 2015-11-02 | 2018-09-04 | 韦里格拉福特公司 | 用于伤口愈合的组合物和方法 |
US11278643B2 (en) | 2016-09-06 | 2022-03-22 | Mayo Foundation For Medical Education And Research | Use of resected liver serum for whole liver-engineering |
EP3547968A4 (de) * | 2016-12-02 | 2020-12-16 | Vascudyne, LLC | Gezüchtete gewebeprothese |
RU2736480C2 (ru) * | 2018-05-15 | 2020-11-17 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Бурятский государственный университет имени Доржи Банзарова" | Способ производства коллаген-ламининового матрикса для заживления язв, ожогов и ран кожи человека |
BR112021001541B1 (pt) * | 2018-08-03 | 2023-05-09 | VeriGraft AB | Método para preparar vasos sanguíneos personalizados |
CN112274699A (zh) * | 2019-07-24 | 2021-01-29 | 西安交通大学医学院第一附属医院 | 小口径组织改良复合型人工血管 |
BR112022016166A2 (pt) * | 2020-02-14 | 2022-10-04 | Kheiros Pater Inovacao S A | Método de produção de biomaterial descelularizado, biomaterial descelularizado e uso do mesmo |
CN114306747A (zh) * | 2021-12-29 | 2022-04-12 | 中国人民解放军陆军军医大学 | 一种小口径心血管植入物及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4034750A (en) | 1975-04-22 | 1977-07-12 | Maurice Seiderman | Electrochemically linking collagen fibrils to animal tissue |
US4798606A (en) | 1985-02-26 | 1989-01-17 | Corvita Corporation | Reinforcing structure for cardiovascular graft |
US4795741A (en) | 1987-05-06 | 1989-01-03 | Biomatrix, Inc. | Compositions for therapeutic percutaneous embolization and the use thereof |
US5475052A (en) | 1988-11-21 | 1995-12-12 | Collagen Corporation | Collagen-synthetic polymer matrices prepared using a multiple step reaction |
US5336616A (en) | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
US5275826A (en) | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
ES2219660T3 (es) * | 1994-03-14 | 2004-12-01 | Cryolife, Inc | Metodos de preparacion de tejidos para implantacion. |
US5716394A (en) | 1994-04-29 | 1998-02-10 | W. L. Gore & Associates, Inc. | Blood contact surfaces using extracellular matrix synthesized in vitro |
US6121041A (en) * | 1996-07-31 | 2000-09-19 | St. Jude Medical, Inc. | Use of microorganisms for decellularizing bioprosthetic tissue |
DK0987998T3 (da) | 1997-04-11 | 2005-01-17 | Cryolife Inc | Decellulering af væv |
US5958669A (en) * | 1997-05-02 | 1999-09-28 | St. Jude Medical, Inc. | Apparatus and method for crosslinking to fix tissue or crosslink molecules to tissue |
US5910170A (en) * | 1997-12-17 | 1999-06-08 | St. Jude Medical, Inc. | Prosthetic heart valve stent utilizing mounting clips |
CN1341032A (zh) | 1999-01-22 | 2002-03-20 | 圣朱德医疗有限公司 | 医学粘合剂 |
US6387116B1 (en) * | 1999-06-30 | 2002-05-14 | Pharmasonics, Inc. | Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts |
US20020077697A1 (en) * | 2000-12-15 | 2002-06-20 | Ranieri John Paul | Processed ratite carotid arteries as xenogeneic small bore vascular grafts |
-
2001
- 2001-04-27 JP JP2001579863A patent/JP2003531685A/ja not_active Withdrawn
- 2001-04-27 AU AU2001255741A patent/AU2001255741B2/en not_active Ceased
- 2001-04-27 AU AU5574101A patent/AU5574101A/xx active Pending
- 2001-04-27 AT AT01928939T patent/ATE390152T1/de not_active IP Right Cessation
- 2001-04-27 WO PCT/US2001/013617 patent/WO2001082992A1/en active IP Right Grant
- 2001-04-27 US US09/844,961 patent/US6689161B2/en not_active Expired - Fee Related
- 2001-04-27 EP EP01928939A patent/EP1278559B1/de not_active Expired - Lifetime
- 2001-04-27 DE DE60133377T patent/DE60133377T2/de not_active Expired - Fee Related
- 2001-04-27 CA CA002407328A patent/CA2407328A1/en not_active Abandoned
-
2003
- 2003-11-06 US US10/702,881 patent/US7060022B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7060022B2 (en) | 2006-06-13 |
US20040137618A1 (en) | 2004-07-15 |
US20010044654A1 (en) | 2001-11-22 |
AU2001255741B2 (en) | 2005-08-04 |
ATE390152T1 (de) | 2008-04-15 |
EP1278559B1 (de) | 2008-03-26 |
CA2407328A1 (en) | 2001-11-08 |
DE60133377T2 (de) | 2009-01-02 |
US6689161B2 (en) | 2004-02-10 |
EP1278559A1 (de) | 2003-01-29 |
AU5574101A (en) | 2001-11-12 |
WO2001082992A1 (en) | 2001-11-08 |
JP2003531685A (ja) | 2003-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60133377D1 (de) | Dezellularisierte gefässprothesen | |
US6395023B1 (en) | Prosthesis with biodegradable surface coating and method for making same | |
Sauvage et al. | Future directions in the development of arterial prostheses for small and medium caliber arteries | |
US6440166B1 (en) | Multilayer and multifunction vascular graft | |
WO2003045467A3 (en) | Intraluminal prosthesis attachment systems and methods | |
ES2166885T3 (es) | Procedimiento de fabricacion de injertos vasculares tubulares. | |
CA2342640A1 (en) | Hernia repair prosthesis | |
WO2005034852A3 (en) | Protein biomaterials and biocoacervates and methods of making and using thereof | |
DE60239878D1 (de) | Sich selbst stützende implantierbare metallprothesen | |
DE69832616D1 (de) | Verwendung von hyaluonsäurederivaten zur herstellung von biomaterial | |
Kenney et al. | Comparison of noncrimped, externally supported (EXS) and crimped, nonsupported Dacron prostheses for axillofemoral and above-knee femoropopliteal bypass | |
IL153946A0 (en) | Artificial vascular grafts, and methods of producing and using same | |
Herring et al. | Patency in canine inferior vena cava grafting: effects of graft material, size, and endothelial seeding | |
Kato et al. | Experimental assessment of newly devised transcatheter stent-graft for aortic dissection | |
JPH11502734A (ja) | 親水性ポリマー組成物で処理された医療機器 | |
Hiratzka et al. | Experimental and clinical results of grafts in the venous system: a current review | |
Nojiri et al. | Aorta-coronary bypass grafting with heparinized vascular grafts in dogs: a preliminary study | |
Richardson et al. | The role of endothelium in the patency of small venous substitutes | |
Van Der Lei et al. | Microarterial grafting into the carotid artery of the rabbit: some considerations concerning species-dependent thrombogenicity | |
Sedlarik et al. | Rapid endothelialization of mieroporous vascular prostheses covered with meshed vascular tissue: a preliminary report | |
US9345808B2 (en) | Structure having fibres which are adhesively bonded to one another in locations | |
Robinson et al. | Patency and healing of polymeric microvenous prostheses implanted into the rat femoral vein by means of the sleeve anastomotic technique | |
Nemes et al. | Application of a vascular graft material (Solcograft®-P) in experimental surgery | |
Norgren et al. | Experimental evaluation of polymerized Dacron grafts in the iliac position of pigs | |
Steinhart et al. | Preformation of microvascular composite free flaps in the rat as an animal model |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |